Top line accelerating.
+5.2% YoY versus +2.0% prior. 3y CAGR +3.3%.
We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $8.5B
Fundamentals as of 2026-03-31
+5.2% YoY versus +2.0% prior. 3y CAGR +3.3%.
Net margin 6.0% versus 14.5% prior (−8.5pp). Operating 8.4%.
P/E 75.3x — 15% above the 5y median of 65.3x. Forward 29.9x hints at EPS expansion next year.
FCF $256.6M versus $236.1M prior. FCF margin 21%; 350% of net income; CapEx 11% of OCF.
Net cash $162.2M versus $151.8M prior. Liquidity: current ratio 3.5.
Dividend distribution not reported versus prior comparable. CapEx $31.0M.
Current: 0.00x
Income · Balance · Cash Flow